[Clinico-functional data concerning chronic asthmatic bronchitis patients treated wih guacetisal].
Guacetisal was administered to a group of patients suffering from chronic asthmatic bronchitis. The drug in question was shown to possess a good fluidifying, expectorant and indirect anti-cough action, by means of an initial increase of the bronchial secretions and a subsequent progressive decrease of secretions towards the end of the treatment. The analysis of the respiratory parameters examined showed no modifications of statistical significance.
D000328:Adult; D000368:Aged; D001241:Aspirin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D001986:Bronchial Spasm / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy*; D003371:Cough / Q000188:drug therapy; D004417:Dyspnea / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012119:Respiration / Q000187:drug effects; D012129:Respiratory Function Tests
D001241:Aspirin; C023557:guacetisal
Rilievi clinico-funzionali in bronchitici cronici asmatici trattati con guacetisal.